High prescribing and state-level variation in z-drug use among Medicare patients
Anderson, K. E.; Basting, J. L.; Gifeisman, R. I.; Harris, D. J.; Rajan, A. R.; McCall, K. L.; Piper, B. J.
Show abstract
BackgroundZ-drugs are nonbenzodiazepine hypnotics used for sleep initiation and maintenance that have been shown to increase the risk of fall-related injuries in patients aged 65 and older. The American Geriatrics Society Beers criteria classifies them as a high-risk medication and strongly recommends avoiding prescribing z-drugs to the elderly due to adverse effects. The objective of this study was to determine the prevalence of Z-drug prescribing among Medicare patients. MethodsZ-drug prescription data was extracted from the Centers for Medicare and Medicaid Services State Drug Utilization Data (CMS SDUD) for 2018. For all 50 states, the number of prescriptions per 100 Medicare enrollees and days-supply per prescription was determined. The percentage of total prescriptions prescribed by each specialty and the average number of prescriptions prescribed by providers within each specialty was also determined. ResultsZolpidem was the most prescribed z-drug, making up 95.0% of all z-drug prescriptions. Prescriptions per 100 enrollees were significantly elevated in Utah (28.2) and Arkansas (26.7) and significantly lower in Hawaii (9.3) relative to the national average (17.5). The specialties family medicine (32.1%), internal medicine (31.4%), and psychiatry (11.7%) made up the largest percentages of total prescriptions. The number of prescriptions per provider was significantly elevated for psychiatry relative to other specialties. ConclusionsContrary to the Beers criteria, z-drugs are being prescribed to Medicare enrollees over age 65 at high rates. While sleep disturbances in the elderly should not be ignored, alternative therapies must be considered to avoid the serious adverse effects of z-drugs. Key PointsMore than one-half million Medicare patients received z-drug prescriptions in 2018 that were inconsistent with the Beers criteria. Z-drug prescriptions per 100,000 Medicare patients were significantly elevated in Utah and Arkansas. Family Medicine had the highest number of prescriptions out of all medical specialties. Psychiatry had a significantly higher number of prescriptions per provider compared to all other specialties.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients 94%
- A qualitative exploration of barriers to efficient and effective Structured Medication Reviews in Primary Care: Findings from the DynAIRx study 92%
- Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders 92%
Similar papers in this journal
- Declines, and Pronounced Regional Disparities, in Meperidine Use in the United States 96%
- Pharmacoepidemiology of Oxycodone in the USA: an observational study of ARCOS, Medicaid, and Medicare drug databases 93%
- Suspected Adverse Drug Reactions of the Type 2 Antidiabetic Drug Class Dipeptidyl-Peptidase IV inhibitors (DPP4i): Can polypharmacology help explain? 90%
Similar papers in this journal
- Medication Clusters at Hospital Discharge and Risk of Adverse Drug Events at 30-days Post-Discharge: A Population-based Cohort Study of Older Adults 95%
- Medication adherence and hospitalizations in older patients with coronary heart disease in Vietnam 91%
- A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model 90%
Similar papers in this journal
- Effects of pharmacogenomic (PGx) testing on clinical pain management prescriptions, a retrospective study 89%
- Challenges in Implementing a Mobile AI Chatbot Intervention for Depression Among Youth on Psychiatric Waiting Lists: A Randomized Control Study Termination Report 88%
- Determinants of Periodic Health Examination Uptake: Insights from a Jordanian Cross-Sectional Study 88%
Similar papers in this journal
- Effects of memantine and high dose vitamin D on gait in the APP/PS1 mouse model of Alzheimer's disease following vitamin D deprivation 88%
- A Qualitative Study of People with Alzheimer’s Disease in a Memory Clinic Considering Lecanemab Treatment 88%
- Investigating the Efficacy of Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects: A Pilot Study 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.